𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia : A Cancer and Leukemia Group B study

✍ Scribed by Alessandro Laviano; Maurizio Muscaritoli; Filippo Rossi-Fanelli

Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
48 KB
Volume
103
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Phase II study of high-dose fish oil cap
Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia : A Cancer and Leukemia Group B study
✍ C. Patrick Burns; Susan Halabi; Gerald Clamon; Ellen Kaplan; Raymond J. Hohl; Ja πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 133 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The authors undertook a multiinstitutional Phase II cooperative group study to examine the potential of oral fish oil fatty acid supplements administered at high doses to slow weight loss and to improve quality of life in patients with malignancy‐related cachexia. ## MET

Weekly, high-dose paclitaxel in advanced
Weekly, high-dose paclitaxel in advanced lung carcinoma : A Phase II study with pharmacokinetics by the Cancer and Leukemia Group B
✍ Wallace Akerley; James E. Herndon; Merrill J. Egorin; Alan P. Lyss; Hedy L. Kind πŸ“‚ Article πŸ“… 2003 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The Cancer and Leukemia Group B conducted a Phase II trial to evaluate the efficacy, toxicity, and pharmacokinetics of paclitaxel administered at a maximum dose density for patients with chemotherapy‐naΓ―ve, advanced‐stage non–small cell lung carcinoma (NSCLC). ## METHODS

A randomized study comparing standard ve
A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma : Cancer and Leukemia Group B study 9181
✍ Nancy A. Dawson; Mark Conaway; Susan Halabi; Eric P. Winer; Eric J. Small; Diana πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 105 KB πŸ‘ 2 views

## BACKGROUND. Megestrol acetate (MA) is a synthetic progestin with reported activity in both hormone-sensitive and hormone-refractory prostate carcinoma (HRPC). Based on limited data suggesting a possible dose-response effect, a trial was initiated to compare standard versus moderately high dose M

Phase II trial of etoposide and cisplati
Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: A cancer and leukemia group B study
✍ Graziano, Stephen L. ;Lee, Kewchang ;Propert, Kathleen J. ;Tinsley, Roger ;Hayes πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 466 KB

## Abstract A phase II trial of etoposide and cisplatin for patients with previously treated small cell lung cancer was carried out by CALGB from June 1983 to May 1984. Thirty‐five evaluable patients who had failed one prior chemotherapy regimen were treated with etoposide 80 mg/m^2^ and cisplatin